Published in J Biol Chem on January 18, 2001
Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo. J Virol (2004) 1.64
Regulation of HIV-1 latency by T-cell activation. Cytokine (2007) 1.48
Cyclin-dependent kinase 9 (Cdk9) of fission yeast is activated by the CDK-activating kinase Csk1, overlaps functionally with the TFIIH-associated kinase Mcs6, and associates with the mRNA cap methyltransferase Pcm1 in vivo. Mol Cell Biol (2006) 1.15
The Tat/TAR-dependent phosphorylation of RNA polymerase II C-terminal domain stimulates cotranscriptional capping of HIV-1 mRNA. Proc Natl Acad Sci U S A (2003) 1.13
Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5. Retrovirology (2004) 1.05
mRNA capping enzyme activity is coupled to an early transcription elongation. Mol Cell Biol (2004) 1.02
Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs. Proc Natl Acad Sci U S A (2010) 0.99
Lost in transcription: molecular mechanisms that control HIV latency. Viruses (2013) 0.96
Construction of a doxycycline-dependent simian immunodeficiency virus reveals a nontranscriptional function of tat in viral replication. J Virol (2007) 0.92
The HIV-1 Tat protein has a versatile role in activating viral transcription. J Virol (2011) 0.91
The DEAD-box helicase DDX3 substitutes for the cap-binding protein eIF4E to promote compartmentalized translation initiation of the HIV-1 genomic RNA. Nucleic Acids Res (2013) 0.89
The cytoplasmic fate of an mRNP is determined cotranscriptionally: exception or rule? Genes Dev (2010) 0.89
Kick-sTARting HIV-1 transcription elongation by 7SK snRNP deporTATion. Nat Struct Mol Biol (2010) 0.89
Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins. Virology (2007) 0.88
A mutant tat protein inhibits HIV-1 reverse transcription by targeting the reverse transcription complex. J Virol (2015) 0.79
Transcriptional start site heterogeneity modulates the structure and function of the HIV-1 genome. Proc Natl Acad Sci U S A (2016) 0.78
Putting an 'End' to HIV mRNAs: capping and polyadenylation as potential therapeutic targets. AIDS Res Ther (2013) 0.76
Translational Control of the HIV Unspliced Genomic RNA. Viruses (2015) 0.76
A gene-specific role for the Ssu72 RNAPII CTD phosphatase in HIV-1 Tat transactivation. Genes Dev (2014) 0.76
NMR Studies of the Structure and Function of the HIV-1 5'-Leader. Viruses (2016) 0.75
Tat-dependent production of an HIV-1 TAR-encoded miRNA-like small RNA. Nucleic Acids Res (2016) 0.75
5'-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev (1997) 6.68
Dynamic association of capping enzymes with transcribing RNA polymerase II. Genes Dev (2000) 4.47
Distinct roles for CTD Ser-2 and Ser-5 phosphorylation in the recruitment and allosteric activation of mammalian mRNA capping enzyme. Mol Cell (1999) 3.73
X-ray crystallography reveals a large conformational change during guanyl transfer by mRNA capping enzymes. Cell (1997) 3.07
Active disruption of an RNA-protein interaction by a DExH/D RNA helicase. Science (2001) 3.05
Purification and characterization of a transcription termination factor from vaccinia virions. J Biol Chem (1987) 2.83
Mechanism of mRNA capping by vaccinia virus guanylyltransferase: characterization of an enzyme--guanylate intermediate. Proc Natl Acad Sci U S A (1981) 2.65
Purification of a factor required for transcription of vaccinia virus early genes. J Biol Chem (1988) 2.52
The DExH protein NPH-II is a processive and directional motor for unwinding RNA. Nature (2000) 2.48
Conservation of structure and mechanism between eukaryotic topoisomerase I and site-specific recombinases. Cell (1998) 2.40
The yeast tRNA splicing endonuclease: a tetrameric enzyme with two active site subunits homologous to the archaeal tRNA endonucleases. Cell (1997) 2.12
Purification and properties of vaccinia virus DNA-dependent RNA polymerase. J Biol Chem (1980) 2.05
Crystal structure of eukaryotic DNA ligase-adenylate illuminates the mechanism of nick sensing and strand joining. Mol Cell (2000) 2.03
Site-specific ribonuclease activity of eukaryotic DNA topoisomerase I. Mol Cell (1997) 1.95
The guanylyltransferase domain of mammalian mRNA capping enzyme binds to the phosphorylated carboxyl-terminal domain of RNA polymerase II. J Biol Chem (1998) 1.91
DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation. J Biol Chem (2000) 1.85
Phylogeny of mRNA capping enzymes. Proc Natl Acad Sci U S A (1997) 1.84
Yeast mRNA cap methyltransferase is a 50-kilodalton protein encoded by an essential gene. Mol Cell Biol (1995) 1.82
Moderate to severe obstructive sleep apnoea patients is associated with a higher incidence of visual field defect. Eye (Lond) (2006) 1.80
Mutational analysis of yeast mRNA capping enzyme. Proc Natl Acad Sci U S A (1994) 1.73
Structure and mechanism of yeast RNA triphosphatase: an essential component of the mRNA capping apparatus. Cell (1999) 1.72
Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component. J Virol (1993) 1.68
Characterization of ts 16, a temperature-sensitive mutant of vaccinia virus. J Virol (1995) 1.66
A freeze-frame view of eukaryotic transcription during elongation and capping of nascent mRNA. Science (1992) 1.65
Three RNA polymerase II carboxyl-terminal domain kinases display distinct substrate preferences. J Biol Chem (2001) 1.63
Vaccinia virus morphogenesis is blocked by temperature-sensitive mutations in the F10 gene, which encodes protein kinase 2. J Virol (1995) 1.62
Catalytic mechanism of DNA topoisomerase IB. Mol Cell (2000) 1.61
Mutational analysis of vaccinia virus nucleoside triphosphate phosphohydrolase II, a DExH box RNA helicase. J Virol (1995) 1.59
Mutational analysis of Chlorella virus DNA ligase: catalytic roles of domain I and motif VI. Nucleic Acids Res (1998) 1.59
Characterization of an ATP-dependent DNA ligase encoded by Chlorella virus PBCV-1. J Virol (1997) 1.57
Covalent catalysis in nucleotidyl transfer. A KTDG motif essential for enzyme-GMP complex formation by mRNA capping enzyme is conserved at the active sites of RNA and DNA ligases. J Biol Chem (1993) 1.56
Sleep-related injury in the elderly--an epidemiological study in Hong Kong. Sleep (2000) 1.56
Yeast and viral RNA 5' triphosphatases comprise a new nucleoside triphosphatase family. J Biol Chem (1998) 1.47
Vaccinia virus gene D12L encodes the small subunit of the viral mRNA capping enzyme. Virology (1989) 1.46
Chlorella virus DNA ligase: nick recognition and mutational analysis. Nucleic Acids Res (1998) 1.46
Vaccinia DNA topoisomerase I: single-turnover and steady-state kinetic analysis of the DNA strand cleavage and ligation reactions. Biochemistry (1994) 1.46
The QRxGRxGRxxxG motif of the vaccinia virus DExH box RNA helicase NPH-II is required for ATP hydrolysis and RNA unwinding but not for RNA binding. J Virol (1996) 1.44
Mutational analysis of Escherichia coli DNA ligase identifies amino acids required for nick-ligation in vitro and for in vivo complementation of the growth of yeast cells deleted for CDC9 and LIG4. Nucleic Acids Res (1999) 1.44
Starting a laparoscopic hepatectomy programme. Singapore Med J (2009) 1.42
A controlled study of sleep related disordered breathing in obese children. Arch Dis Child (2003) 1.42
Domain structure and mutational analysis of T4 polynucleotide kinase. J Biol Chem (2001) 1.41
The role of ATP in in vitro vaccinia virus RNA synthesis effects of AMP-PNP and ATP gamma S. J Biol Chem (1980) 1.39
RNA capping by HeLa cell RNA guanylyltransferase. Characterization of a covalent protein-guanylate intermediate. J Biol Chem (1982) 1.38
Accelerated mRNA decay in conditional mutants of yeast mRNA capping enzyme. Nucleic Acids Res (1998) 1.38
The nucleoside triphosphatase and helicase activities of vaccinia virus NPH-II are essential for virus replication. J Virol (1998) 1.38
Characterization of human, Schizosaccharomyces pombe, and Candida albicans mRNA cap methyltransferases and complete replacement of the yeast capping apparatus by mammalian enzymes. J Biol Chem (1999) 1.38
Structure-function analysis of the mRNA cap methyltransferase of Saccharomyces cerevisiae. J Biol Chem (1997) 1.37
Footprinting of Chlorella virus DNA ligase bound at a nick in duplex DNA. J Biol Chem (1999) 1.34
Pathology of androgen deprivation therapy in prostate carcinoma. A comparative study of 173 patients. Cancer (1995) 1.34
Tat-associated kinase (P-TEFb): a component of transcription preinitiation and elongation complexes. J Biol Chem (1999) 1.33
Conditional inactivation of mRNA capping enzyme affects yeast pre-mRNA splicing in vivo. RNA (1996) 1.32
Mutational analysis of the Saccharomyces cerevisiae ABD1 gene: cap methyltransferase activity is essential for cell growth. Mol Cell Biol (1996) 1.32
The length, phosphorylation state, and primary structure of the RNA polymerase II carboxyl-terminal domain dictate interactions with mRNA capping enzymes. J Biol Chem (2001) 1.31
Structure and mechanism of the RNA triphosphatase component of mammalian mRNA capping enzyme. EMBO J (2001) 1.31
Prenatal diagnosis of metachromatic leukodystrophy in a family with pseudo arylsulfatase A deficiency by the cerebroside sulfate loading test. Pediatr Res (1980) 1.29
The D1 and D12 subunits are both essential for the transcription termination factor activity of vaccinia virus capping enzyme. J Virol (1995) 1.29
Nascent RNA cleavage by purified ternary complexes of vaccinia RNA polymerase. J Biol Chem (1993) 1.27
HIV-1 TAR RNA enhances the interaction between Tat and cyclin T1. J Biol Chem (2000) 1.26
Ocular colobomata, cardiac defect, and other anomalies: a study of seven cases including two sibs. J Med Genet (1975) 1.26
The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer (1997) 1.24
Resolution of Holliday junctions by eukaryotic DNA topoisomerase I. Proc Natl Acad Sci U S A (1996) 1.24
Mutational analysis of mRNA capping enzyme identifies amino acids involved in GTP binding, enzyme-guanylate formation, and GMP transfer to RNA. Mol Cell Biol (1995) 1.23
Structure-function analysis of yeast mRNA cap methyltransferase and high-copy suppression of conditional mutants by AdoMet synthase and the ubiquitin conjugating enzyme Cdc34p. Genetics (2000) 1.22
Expression and characterization of an RNA capping enzyme encoded by Chlorella virus PBCV-1. J Virol (1996) 1.22
Factor-dependent transcription termination by vaccinia RNA polymerase. Kinetic coupling and requirement for ATP hydrolysis. J Biol Chem (1994) 1.22
Schwann cell responses to cyclic AMP: proliferation, change in shape, and appearance of surface galactocerebroside. Brain Res (1986) 1.21
Genetic, physical, and functional interactions between the triphosphatase and guanylyltransferase components of the yeast mRNA capping apparatus. Mol Cell Biol (1998) 1.21
Risk of betel chewing for oesophageal cancer in Taiwan. Br J Cancer (2001) 1.20
RNA 5'-triphosphatase, nucleoside triphosphatase, and guanylyltransferase activities of baculovirus LEF-4 protein. J Virol (1998) 1.19
Discrete functional stages of vaccinia virus early transcription during a single round of RNA synthesis in vitro. J Biol Chem (1991) 1.19
Specificity and fidelity of strand joining by Chlorella virus DNA ligase. Nucleic Acids Res (1998) 1.18
Characterization of an ATP-dependent DNA ligase from the thermophilic archaeon Methanobacterium thermoautotrophicum. Nucleic Acids Res (2000) 1.18
Temperature-sensitive mutations in the vaccinia virus H4 gene encoding a component of the virion RNA polymerase. J Virol (1992) 1.18
Complete sequence of the HLA DQ alpha and DQ beta cDNA from a DR5/DQw3 cell line. J Immunol (1987) 1.18
Vaccinia virions lacking the RNA helicase nucleoside triphosphate phosphohydrolase II are defective in early transcription. J Virol (1996) 1.17
Methyltransferase and subunit association domains of vaccinia virus mRNA capping enzyme. J Biol Chem (1992) 1.16
Physical and functional characterization of the double-stranded RNA binding protein encoded by the vaccinia virus E3 gene. Virology (1996) 1.15
Mutational analysis of 39 residues of vaccinia DNA topoisomerase identifies Lys-220, Arg-223, and Asn-228 as important for covalent catalysis. J Biol Chem (1997) 1.14
Stereochemical outcome and kinetic effects of Rp- and Sp-phosphorothioate substitutions at the cleavage site of vaccinia type I DNA topoisomerase. Biochemistry (2000) 1.14
Inhibition of gene expression in human cells through small molecule-RNA interactions. Proc Natl Acad Sci U S A (1999) 1.13
The change of beta-adrenergic system in lead-induced hypertension. Toxicol Appl Pharmacol (2000) 1.13
Characterization of Schizosaccharomyces pombe RNA triphosphatase. Nucleic Acids Res (2001) 1.13
Nick sensing by vaccinia virus DNA ligase requires a 5' phosphate at the nick and occupancy of the adenylate binding site on the enzyme. J Virol (1997) 1.12
Proteolytic footprinting of vaccinia topoisomerase bound to DNA. J Biol Chem (1995) 1.12
Mutational analysis of the RNA triphosphatase component of vaccinia virus mRNA capping enzyme. J Virol (1996) 1.12
Mutational analysis of the vaccinia virus E3 protein defines amino acid residues involved in E3 binding to double-stranded RNA. J Virol (1996) 1.10
Domain structure of vaccinia DNA ligase. Nucleic Acids Res (1997) 1.10
Stability of ternary transcription complexes of vaccinia virus RNA polymerase at promoter-proximal positions. J Biol Chem (1992) 1.09
NAD+-dependent DNA ligase encoded by a eukaryotic virus. J Biol Chem (2001) 1.09
Vaccinia topoisomerase binds circumferentially to DNA. J Biol Chem (1994) 1.08
Purification and use of vaccinia virus messenger RNA capping enzyme. Methods Enzymol (1990) 1.08
Histidine 265 is important for covalent catalysis by vaccinia topoisomerase and is conserved in all eukaryotic type I enzymes. J Biol Chem (1997) 1.08
Peptide inhibitors of DNA cleavage by tyrosine recombinases and topoisomerases. J Mol Biol (2000) 1.08
Heterogeneity of human blood monocyte: two subpopulations with different sizes, phenotypes and functions. Immunology (1992) 1.07